← Evidence map

ArticleCell reports2019

Liver-Type Glutaminase GLS2 Is a Druggable Metabolic Node in Luminal-Subtype Breast Cancer.

Michael J Lukey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

61 papers cite itlatest 60 shown

2019
…
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31577957